Apolipoprotein E polymorphism affects the response to pravastatin on plasma apolipoproteins in diabetic patients
- 30 April 1993
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 20 (1) , 21-27
- https://doi.org/10.1016/0168-8227(93)90018-z
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Disparity between apolipoprotein E phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin-dependent diabetes mellitusClinica Chimica Acta; International Journal of Clinical Chemistry, 1991
- The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemiaMetabolism, 1990
- Phenotypes of apolipoprotein E and abnormalities in lipid metabolism in patients with non-insulin-dependent diabetes mellitusMetabolism, 1988
- Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Increased frequency of apolipoprotein epsilon 4 allele in type II diabetes with hypercholesterolemiaDiabetes, 1987
- Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.BMJ, 1983
- Lipoprotein receptors and cholesterol homeostasisBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1983
- Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modificationBiochemistry, 1981
- Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham StudyDiabetes Care, 1979
- Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in manNature, 1977